Alexion Pharmaceuticals Inc

Visual Financials
Company Name: Alexion Pharmaceuticals Inc
Ticker Symbol: ALXN
CIK Number: 0000899866
WWW Address: http://www.alexionpharm.com
CEO: David Hallal
No. of Employees: 2,924
Common Issue Type: CS
Business Description:Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 127.99 Down -1.64 128.0 128.99 129.59 130.38 127.71 955504
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 28,701.5 224.2 0.00 0.68 0.00 190.0 0.0 193.45 - 110.56
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close127.99$
PE Ratio - LTM190.0
Market Capitalisation28,701.5mil
Latest Shares Outstanding224.2mil
Earnings pS (EPS)0.68$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee890,577$
Effective Tax Rate0.7%
Float161.3mil
Float as % of Shares Outstanding0.7%
Foreign Sales1,651mil
Domestic Sales951mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.30%
Gross Profit Margin91.0%
EBITDA Margin27.4%
Pre-Tax Profit Margin19.1%
Assets Turnover30.0%
Return on Assets (ROA)1.7%
Return on Equity (ROE)2.5%
Return on Capital Invested (ROCI)2.2%
Current Ratio3.4
Leverage Ratio (Assets/Equity)1.6
Interest Cover11.4
Total Debt/Equity (Gearing Ratio)0.44
LT Debt/Total Capital29.0%
Working Capital pS7.61$
Cash pS0.00$
Book-Value pS36.56$
Tangible Book-Value pS-6.68$
Cash Flow pS3.63$
Free Cash Flow pS2.37$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.54
Price/Tangible Book Ratio0.00
Price/Cash Flow35.7
Price/Free Cash Flow54.6
P/E as % of Industry Group241.0%
P/E as % of Sector Segment48.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----5.1-5976,857873,955
4 Weeks138.40127.46133.51-2.9-31,224,84625,721,776
13 Weeks157.02110.56150.88-14.1-181,825,862116,855,201
26 Weeks162.00110.56140.80-7.9-211,605,297205,478,053
52 Weeks193.45110.56172.19-24.7-351,573,148398,006,538
YTD187.59110.56--29.8-381,658,854275,369,780
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
131.26132.42127.49137.82147.570.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.370.70.32
Income0.080.0-0.17
Dividend0.0
Capital Spending0.33NA0.18
R&D28.58NA38.53
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %38.538.544.8
Earnings %81.081.045.4
EPS %78.378.340.7
EPS $0.180.180.37
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio13.00
Current Ratio3.4
Quick Ratio (Acid Test)2.7
Liquidity Ratio (Cash)3.33
Receivables Turnover5.4
Average Collection Period67
Working Capital/Equity20.7
Working Capital pS7.58
Cash-Flow pS3.13
Free Cash-Flow pS1.80
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio4.09
Financial Leverage Ratio (Assets/Equity)0.4
Debt Ratio27.5
Total Debt/Equity (Gearing Ratio)0.44
LT Debt/Equity0.42
LT Debt/Capital Invested35.5
LT Debt/Total Liabilities91.0
Interest Cover11.4
Interest/Capital Invested0.38
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.21
Current P/E Ratio - LTM190.00
Enterprise Value (EV)/EBITDA44.28
Enterprise Value (EV)/Free Cash Flow75.29
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.54
Price/Cash Flow Ratio35.7
Price/Free Cash Flow Ratio - LTM54.6
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM72.3
P/E Ratio (26 weeks ago) - LTM83.4
P/E Ratio (52 weeks ago) - LTM93.3
5-Y High P/E Ratio696.3
5-Y Low P/E Ratio174.1
5-Y Average P/E Ratio66.9
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group241.0
P/E as % of Sector Segment48.0
Current 12 Month Normalized P/E Ratio - LTM55.1
PER SHARE FIGURES
LT Debt pS24.81
Current Liabilities pS5.43
Tangible Book Value pS - LTM-6.68
Book Value pS - LTM36.56
Capital Invested pS52.24
Cash pS - LTM0.00
Cash Flow pS - LTM3.63
Free Cash Flow pS - LTM2.37
Earnings pS (EPS)0.68
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin14.93
Free Cash Flow Margin 5YEAR AVG13.33
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity0.32
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.22
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.30
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin91.0
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM27.4
EBIT Margin - LTM21.0
Pre-Tax Profit Margin0.3
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate24.7
Effective Tax Rate - 5YEAR AVRG.19.0
EFFICIENCY RATIOS
Cash Conversion Cycle7,872,724
Revenue per Employee890,577
Net Income per Employee49,379
Average Collection Period7,872,724
Receivables Turnover5.4
Day's Inventory Turnover Ratio
Inventory Turnover1.0
Inventory/Sales11.1
Accounts Payble/Sales2.20
Assets/Revenue3.33
Net Working Capital Turnover1.53
Fixed Assets Turnover0.24
Total Assets Turnover0.3
Revenue per $ Cash2.58
Revenue per $ Plant3.74
Revenue per $ Common Equity0.32
Revenue per $ Capital Invested0.22
Selling, General & Adm/tive (SG&A) as % of Revenue33.1
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue27.2
R&D Expense as % of Revenue - 5YEAR AVRG.27.2

  
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20160829 21:50:24